Address
Email address
Phone number
https://tbdpharmatech.comTBD Pharmatech – Contract Development and ManufacturingTBD Pharmatech specialises in Active Pharmaceutical Ingredients, advanced intermediates, and the development and production of fine chemicals
Name
OÜ KALTEC
Registry code
10804159
VAT number
EE101176082
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
27.11.2001 (23)
Financial year
01.01-31.12
Capital
2 566.00 €
Activity
70221 - Business and other management consultancy activities
-
-
-
-
-
-
-
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Andrus Tasa
| 100% - 2 566.00 EUR | Board member | - | Founder |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| aktsiaselts Biotehnoloogia Park Kinnisvara 10834232 | 50% - 74 124.00 EUR | - | - | FounderShareholder |
| Biolumix Chemicals OÜ 12805625 | 100% - 4 223.00 EUR | - | - | Founder |
| KemInvent OÜ 12771636 | 59% - 3 496.00 EUR | - | - | FounderFounder |
| osaühing Technologicum 11318780 | 100% - 2 556.00 EUR | - | - | |
| DosCero OÜ 16694813 | - | - | - | Founder |
| Marecrona OÜ 16694826 | - | - | - | Founder |
| Tartu BT Park OÜ 14217720 | - | - | - | Founder |
| Baltic Innovation Agency OÜ 10943240 | - | - | - | Founder |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q4 | 25 000 € | 4 702.46 € | 2 739.98 € | 1 |
| 2024 Q3 | 36 639.34 € | 3 776.87 € | 357.39 € | 1 |
| 2024 Q2 | 45 800 € | 8 025.94 € | 357.39 € | - |
| 2024 Q1 | 16 900 € | 2 705.56 € | 357.39 € | - |
| 2023 Q4 | 4 300 € | 483.09 € | 357.39 € | - |
| 2023 Q3 | 18 100 € | 514.68 € | 357.39 € | - |
| 2023 Q2 | 144 050 € | 25 232.25 € | 357.39 € | - |
| 2023 Q1 | 88 240 € | 21 079.13 € | 357.39 € | - |
| 2022 Q4 | 14 400 € | 2 346.54 € | 357.39 € | - |
| 2022 Q3 | 304 822 € | 58 925.38 € | 357.39 € | - |
| 2022 Q2 | 140 000 € | 20 579.32 € | 257.39 € | - |
| 2022 Q1 | 120 195 € | 23 766.3 € | 331.12 € | - |
| 2021 Q4 | 177 150 € | 36 032.69 € | 1 529.31 € | - |
| 2021 Q3 | 314 414 € | 43 009.4 € | 377.17 € | 1 |
| 2021 Q2 | 92 600 € | 18 557.03 € | 462.06 € | 1 |
| 2021 Q1 | 17 600 € | 3 538.56 € | 462.06 € | 1 |
| 2020 Q4 | 115 600 € | 22 457.36 € | 462.06 € | 1 |
| 2020 Q3 | 136 550 € | 26 887.44 € | 513.4 € | 1 |
| 2020 Q2 | 123 922.38 € | 25 133.52 € | 616.08 € | 1 |
| 2020 Q1 | 143 800 € | 29 058.27 € | 616.08 € | - |
